Clinical performance of sars-cov-2 molecular tests
Detection Principle
NucleicAcid-PCR based
Target
Depending on kit: E gene, N2 gene, ORF1ab, RdRp
Testing Method Category
Testing Method
kit
Testing Method - Additional Info
determine the clinical performance characteristics of SARS-CoV-2 molecular assays for diagnosis and stratification of COVID-19 patients and to determine the dynamics of SARS-CoV-2 molecular assay results over time in a large data set from multiple hospital locations in the New York City area
Reported Performance
sensitivity: between 58% and 96%, depending on the unknown number of false-negative results in single-tested patients
Sample Size
27,377 samples from 22,338 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements